drugset / Trial / NCT04333589
Corona Virus Disease 2019 Patients Whose Nucleic Acids Changed From Negative to Positive
RandomizedParallel-groupOpen-labelTreatment
Summary
To investigate the mechanism, clinical outcome and therapeutic efficacy with favipiravir of Corona Virus Disease 2019 patients whose nucleic acids changed from negative to positive.
Timeline
- Start
- 2020-04-01
- Primary completion
- 2020-06-01
- Completion
- 2020-09-15
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Favipiravir | Small molecule | 600 mg | Oral |